Article Per Year (5 Year)
p-Index From 2020 - 2025
0.408
P-Index
This Author published in this journals
All Journal IJF (Indonesia Jurnal Farmasi)
Ari Simbara
Unknown Affiliation
Medicine & Pharmacology

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
EDUKASI GERAKAN MASYARAKAT CERDAS MENGGUNAKAN OBAT (GEMA CERMAT) UNTUK MENINGKATKAN PENGETAHUAN SWAMEDIKASI Ari Simbara; Arina Zulfah Primananda; Aji Tetuko; Chaerani Noor Savitri
IJF (Indonesia Jurnal Farmasi) Vol 4, No 1 (2019): Indonesia Jurnal Farmasi
Publisher : Universitas Muhammadiyah Kudus

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.26751/ijf.v4i1.797

Abstract

Berdasarkan  survey  Sosial  Ekonomi  Nasional  (SUSENAS)  menunjukkan  bahwa lebih dari 66% masyarakat melakukan pengobatan sendiri (swamedikasi). Data ini membuktikan  bahwa  sejumlah  besar  masyarakat  melakukan  swamedikasi,  untuk  itu  harus diimbangi dengan informasi yang memadai, sehingga tidak terjadi kesalahan. Melalui GEMA CERMAT diharapkan penggunaan obat secara rasional oleh masyarakat dapat tercapai,  meliputi ; pengetahuan komposisi, indikasi, dosis dan cara pakai, efek samping, kontra indikasi, dan tanggal kadaluarsa  obat. Penelitian ini bertujuan untuk mengetahui pengaruh edukasi GEMA CERMAT terhadap tingkat pengetahuan swamedikasi. Penelitian ini menggunakan desain penelitian pra-experimental one-group pretest-posttest dengan menggunakan pendekatan waktu Cross sectional. Analisis hasil menggunakan uji t-test  berpasangan. Analisis hasil penelitian, terjadi peningkatan pengetahuan swamedikasi dari data uji post test. Dengan uji t-test berpasangan diperoleh nilai signifikansi 0,000, yang menunjukkan adanya pengaruh edukasi GEMA CERMAT terhadap pengetahuan swamedikasi. Kesimpulan, edukasi GEMA CERMAT dapat meningkatkan pengetahuan masyarakat tentang swamedikasi.
HUBUNGAN KARAKTERISTIK DENGAN PERIODE RAWAT INAP PASIEN COVID-19 YANG MENDAPAT TERAPI FAVIPIRAVIR Endang Setyowati; Rika Muharyanti; Ari Simbara; Nura Ali Dahbul
IJF (Indonesia Jurnal Farmasi) Vol 7, No 2 (2022): Indonesia Jurnal Farmasi
Publisher : Universitas Muhammadiyah Kudus

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.26751/ijf.v7i2.1753

Abstract

Background: Covid-19 is a disease caused by the SARS-CoV-2 (Server acute respiratory syndrome coronavirus 2) virus. The transmission of Covid-19 was so fast the on January 30, 2020 WHO declared Coronavirus as KKMD. The high number of cases of Covid-19 has resulted in a lack of capacity for health facilities, thus making inpatient medical services less than optimal and adequate.    Objective: To determine the relationship between characteristics with the period of hospitalization of Covid-19 patients receiving favipiravir therapy at the Mitra Bangsa Hospital, Pati.Methods: this type of analytic observational study with a retrospective approach, was conducted in May-June 2021 at Mitra Bangsa Hospital, Pati. Purposive sampling, and data collection using Covid-19 patient medical record. The number of sampels obtained was 59 respondents, and data analysis was carried out statistically using bivariat analysis with Chi Square test.Results: the most gender was male 32 patients (54.2%), the most age 46-59 as many 29 patients (49.2%), then Covid-19 patients had the most comorbidities as many as 39 patients (67.8%) with the most common disiase was diabetes melitus with 19 patiens (32.2%). The result of the Chi Square test showed that there was a relationship between gender with lengts of stay p-value: 0.640, relationship between age with length of stay p-value: 0.806, and comorbid relationship with length of stay p-value: 0.301.Conclusion: There is relationship between characteristics with the period of hospitalization of Covid-19 patients receiving favipiravir therapy at the Mitra Bangsa hospital Pati.Keywords: Covid-19, Favipiravir, Hospitalization
Co-Authors Aji Tetuko Arina Zulfah Primananda Chaerani Noor Savitri Endang Setyowati Nura Ali Dahbul Rika Muharyanti